Indications
Clopidogrel is indicated in adults for the prevention of atherothrombotic events in: Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.
Composition
- Active substance
- clopidogrel (as hydrochloride)
- International name (INN)
- clopidogrel
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Clopidogrel DURA
- Active substance
- clopidogrel (as hydrochloride)
- ATC code
- B01AC04
- Therapeutic area
- Peripheral Vascular Diseases, Stroke, Myocardial Infarction